Financial News
Articles published by Axonics, Inc.
![](https://mms.businesswire.com/media/20221116005768/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Ranked No. 4 on the 2022 Deloitte Technology Fast 500™ List of the Fastest Growing Companies in North America
November 16, 2022
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20221031005272/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Reports Third Quarter 2022 Financial Results
October 31, 2022
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20221010005006/en/788134/5/Axonics_Logo_-_Color.jpg)
From Axonics, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220908005376/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Announces First Patient Implants in Canada With New Recharge-Free Sacral Neuromodulation System
September 08, 2022
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20220818005007/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® to Participate in September Investor Conferences
August 18, 2022
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20220817005035/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20220805005473/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20220802006213/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Announces Pricing of Public Offering of Common Stock
August 02, 2022
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20220802006118/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Announces Proposed Public Offering of Common Stock
August 02, 2022
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20220801005281/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Reports Second Quarter 2022 Financial Results
August 01, 2022
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20220711005237/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20220531005190/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Files PMA Supplement with FDA for Fourth Generation Rechargeable Neurostimulator
May 31, 2022
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20220505006004/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20220426005508/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20220419005467/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Announces Comprehensive Launch of the Axonics F15™ Recharge-Free Sacral Neuromodulation System
April 19, 2022
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20220414005813/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20220404005257/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20220224005983/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Reports Fourth Quarter and Fiscal Year 2021 Financial Results
February 24, 2022
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20220203005002/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24
February 03, 2022
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20220201005579/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® to Participate in SVB Leerink Virtual Healthcare Conference
February 01, 2022
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20220125005307/en/788134/5/Axonics_Logo_-_Color.jpg)
New Study Finds More Than 60% of Adult Women in the U.S. Experience Urinary Incontinence
January 25, 2022
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20220106005321/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20211130005134/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20211117005433/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Ranked the Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™
November 17, 2021
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20211108005068/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® to Participate in Piper Sandler Virtual Healthcare Conference
November 08, 2021
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20211104005230/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Reports Third Quarter 2021 Financial Results
November 04, 2021
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20211026005491/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20211007005165/en/788134/5/Axonics_Logo_-_Color.jpg)
![](https://mms.businesswire.com/media/20210922006013/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Provides Additional Update on Inter Partes Review Proceedings
September 22, 2021
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
![](https://mms.businesswire.com/media/20210913005859/en/788134/5/Axonics_Logo_-_Color.jpg)
Axonics® Announces Partial Decision on Inter Partes Review Proceedings
September 13, 2021
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.